热烈祝贺!北京大学肿瘤医院郭军教授荣获2022PI桂冠奖-创新奖!
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><img src="https://mmbiz.qpic.cn/mmbiz_png/oHf4BXeKAg3Pxv5X43BNG2A02zVvaNibtVQodQRoIKCzuA9HFjqiac6wBYr30EKgUbruZ4r9gRdosHJpRPsX6BIQ/640?wx_fmt=png&tp=webp&wxfrom=5&wx_lazy=1&wx_co=1" style="width: 50%; margin-bottom: 20px;"></p>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;">千帆竞发,谁与争锋,2022年</span><strong style="color: blue;"><span style="color: black;">第三届“中国生物医药产业链创新风云榜”</span></strong><span style="color: black;">榜单重磅出炉,该榜单主办方<span style="color: black;">是由于</span>中国生物医药产业链创新与转化联盟、南京生物医药产业创新转化中心、药渡、药咖荟、《药学<span style="color: black;">发展</span>》编委会及兴业证券<span style="color: black;">形成</span>。在各中外院士、国家部委<span style="color: black;">关联</span>司领导、全国性学协会<span style="color: black;">表率</span>、高校<span style="color: black;">研究</span>院和临床<span style="color: black;">实验</span><span style="color: black;">公司</span>所专家、投资领域合伙人以及上市与拟上市<span style="color: black;">公司</span>高管<span style="color: black;">一起</span>的</span><span style="color: black;">见证下,邓子新院士宣布,北京大学肿瘤医院郭军教授荣获2022年中国生物医药产业链创新风云榜-<strong style="color: blue;">2022 PI桂冠奖-创新奖</strong>。</span></p>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;"><strong style="color: blue;">专家简介</strong></span></p><img src="https://mmbiz.qpic.cn/mmbiz_png/AtTmw2081Jia7olwNTyfn6mwPwTPpqZMxu9sxGze5dc6EvoicYr1uuibLsZvh84DEMXj7uF15jGNroN7wZOibiabpYQ/640?wx_fmt=png&wxfrom=5&wx_lazy=1&wx_co=1&tp=webp" style="width: 50%; margin-bottom: 20px;">
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;"><strong style="color: blue;">郭军 教授</strong></span></p>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;"><span style="color: black;">专家</span>医师、博士生导师</span></p>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;">北京大学肿瘤医院泌尿与黑色素瘤内科</p>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;">北京大学肿瘤医院副院长 </p>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;">中国临床肿瘤协会(CSCO)副理事长兼秘书长</p>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;">CSCO黑色素瘤专家委员会<span style="color: black;">专家</span>委员</p>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;">CSCO肾癌专家委员会副<span style="color: black;">专家</span>委员</p>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;">CSCO免疫治疗专家委员会副<span style="color: black;">专家</span>委员</p>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;">CSCO尿路上皮癌专委会 副<span style="color: black;">专家</span>委员</p>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;">国际黑色素瘤<span style="color: black;">科研</span>联盟亚太地区主席</p><span style="color: black;">全世界</span>黑色素瘤专家委员会常务委员
<span style="color: black;">郭军教授<span style="color: black;">长时间</span>致力于黑色素瘤、肾癌、前列腺癌等的抗肿瘤新药的<span style="color: black;">开发</span>工作,牵头的58项多中心临床<span style="color: black;">科研</span><span style="color: black;">重点</span>集中在肿瘤的免疫治疗、ADC治疗、靶向治疗,在这些临床<span style="color: black;">科研</span><span style="color: black;">其中</span>有相当多的中国的创新的理念付诸于临床实践并得到检验。</span>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><img src="https://mmbiz.qpic.cn/mmbiz_jpg/oHf4BXeKAg3Pxv5X43BNG2A02zVvaNibtETVic0Smf76ObwN0cXlOBdN51DG0H8X0QMOcJicG6eibXicjflCqW9ic9Vg/640?wx_fmt=jpeg&tp=webp&wxfrom=5&wx_lazy=1&wx_co=1" style="width: 50%; margin-bottom: 20px;"></p>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><img src="https://mmbiz.qpic.cn/mmbiz_jpg/oHf4BXeKAg3Pxv5X43BNG2A02zVvaNibtj9Z5pYhE1Jxa0NNw4t3Fb52IUz4Z65WxIRkdDN9MjNPxq6T9CnEx8w/640?wx_fmt=jpeg&tp=webp&wxfrom=5&wx_lazy=1&wx_co=1" style="width: 50%; margin-bottom: 20px;"></p>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;">2022年ASCO上,郭军教授及其团队共10项<span style="color: black;">科研</span>入选ASCO大会,其中“卡瑞利珠单抗联合阿帕替尼和替莫唑胺一线治疗晚期肢端黑色素瘤的Ⅱ期临床<span style="color: black;">科研</span>”以口头报告的形式重磅<span style="color: black;">颁布</span>,这一创新三联<span style="color: black;">方法</span>取得了客观缓解率(ORR)66.7%,<span style="color: black;">没</span><span style="color: black;">发展</span><span style="color: black;">存活</span>期(PFS)18.4个月的出色数据,是迄今为止国内外已<span style="color: black;">报告</span>的晚期肢端黑色素瘤有效率最高的一线治疗<span style="color: black;">方法</span>。<span style="color: black;">科研</span>结果<span style="color: black;">颁布</span>之后,在业界<span style="color: black;">导致</span>了<span style="color: black;">很强</span>反响和轰动。</span></p>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;">而如今,郭军教授带领下,中国<span style="color: black;">方法</span><span style="color: black;">已然</span>在国际ASCO大会ESMO大会舞台上得到口头报告的发言并且<span style="color: black;">发布</span>在JCO等等杂志上,得到了国际同道的认可,<span style="color: black;">亦</span>在国外的治疗指南<span style="color: black;">其中</span>有着中国的一席之地,而<span style="color: black;">更加多</span>的<span style="color: black;">科研</span><span style="color: black;">亦</span><span style="color: black;">已然</span>写到了中国的CSCO诊疗指南<span style="color: black;">其中</span>。</span></p><span style="color: black;">
<div style="color: black; text-align: left; margin-bottom: 10px;">
<div style="color: black; text-align: left; margin-bottom: 10px;">
<div style="color: black; text-align: left; margin-bottom: 10px;">
<div style="color: black; text-align: left; margin-bottom: 10px;">
<div style="color: black; text-align: left; margin-bottom: 10px;">
<div style="color: black; text-align: left; margin-bottom: 10px;">关闭</div>
<div style="color: black; text-align: left; margin-bottom: 10px;"><strong style="color: blue;">观看<span style="color: black;">更加多</span></strong></div>
<div style="color: black; text-align: left; margin-bottom: 10px;"><span style="color: black;">更加多</span></div>
</div>
</div>
</div>
</div>
<div style="color: black; text-align: left; margin-bottom: 10px;">
<div style="color: black; text-align: left; margin-bottom: 10px;">
<div style="color: black; text-align: left; margin-bottom: 10px;">
<div style="color: black; text-align: left; margin-bottom: 10px;">
<div style="color: black; text-align: left; margin-bottom: 10px;">退出全屏</div>
</div>
</div>
</div>
</div>
<div style="color: black; text-align: left; margin-bottom: 10px;">
<div style="color: black; text-align: left; margin-bottom: 10px;">
<div style="color: black; text-align: left; margin-bottom: 10px;">
<div style="color: black; text-align: left; margin-bottom: 10px;">
<div style="color: black; text-align: left; margin-bottom: 10px;">
<div style="color: black; text-align: left; margin-bottom: 10px;">
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;">视频加载失败,请刷新页面再试</p><a style="color: black;"><img src="data:image/png;base64,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" style="width: 50%; margin-bottom: 20px;"> 刷新 </a>
</div><img src="data:image/png;base64,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" style="width: 50%; margin-bottom: 20px;">
</div>
</div>
</div>
</div>
</div>
</div>
<div style="color: black; text-align: left; margin-bottom: 10px;">
<div style="color: black; text-align: left; margin-bottom: 10px;"> <a style="color: black;"> 视频详情 </a> </div>
</div>
</span><span style="color: black;">以上为郭军教授<span style="color: black;">发布</span>获奖感想视频</span><span style="color: black;">郭军教授<span style="color: black;">得到</span>此次2022年PI桂冠奖-创新奖是对郭军教授团队学术实力的肯定,<span style="color: black;">同期</span><span style="color: black;">亦</span><span style="color: black;">表率</span>着将有<span style="color: black;">更加多</span>的优秀PI在郭军教授的带领下闯出一片新天地。<span style="color: black;">将来</span>,随着临床<span style="color: black;">科研</span>和实践经验的<span style="color: black;">持续</span>丰富和完善,尤其是结合中国<span style="color: black;">病人</span>不同的分子组学特征和不同的<span style="color: black;">疾患</span>亚型,相信郭军教授将做出<span style="color: black;">更加多</span>的中国原创<span style="color: black;">科研</span>,向世界贡献<span style="color: black;">更加多</span>的中国<span style="color: black;">方法</span>,开辟更好的方向和道路!</span><strong style="color: blue;">END</strong>
谷歌外链发布 http://www.fok120.com/ 你的见解独到,让我受益匪浅,期待更多交流。 楼主发的这篇帖子,我觉得非常有道理。 论坛的成果是显著的,但我们不能因为成绩而沾沾自喜。
页:
[1]